DRUGSwww.epgonline.orgDISEASE KNOWLEDGE CENTRESwww.epgonline.orgGUIDELINESwww.epgonline.orgCLINICAL TRIALSwww.epgonline.orgMEDICAL NEWSwww.epgonline.orgLINKSwww.epgonline.org
Members Login
How to use the
Email

Password



EPG News Feed Medical News
EPG Online Disease Knowledge Centres Feed Disease Knowledge
Recent UK Drug Updates Drug Updates
EPG Search
Frequent Searches:
Search
Languages

Medical News Headlines
Expert praises Parkinson's treatment
The treatment of Parkinson's disease with levodopa has been discussed...
Published Thursday 04 December 2008

Annual report finds cancer initiative a success
A new initiative that aims to improve the treatment of...
Published Thursday 04 December 2008

New game could help tackle obesity and diabetes in kids, expert claims
A new scheme from the British Heart Foundation (BHF) will...
Published Thursday 04 December 2008

Some "good cholesterol" not good enough, study suggests
A number of preconceptions about "good" HDL cholesterol have been...
Published Tuesday 02 December 2008

More Medical News
Browse Other Languages
Male hypogonadism is the term used to describe decreased functional activity of the testes with diminished production and action of testosterone. Benign prostatic hyperplasia is a progressive disease defined histologically and characterized by stromal and epithelial cell hyperplasia beginning in the periurethral zone of the prostate. Parkinson's disease (PD) is a degenerative disorder of the central nervous system characterized by the clinically asymmetric onset of resting tremor, bradykinesia, rigidity and postural instability. Calendar of this months Global and European Medical conferences in Healthcare
More NewsEPG Online News
Erectile dysfunction drug 'could help BPH'
22 Aug 2008

A new study has revealed that a daily dose of erectile dysfunction drug tadalafil (Cialis) may help to relieve symptoms of benign prostatic hyperplasia (BPH).

The study, which is published in the October 2008 issue of the Journal of Urology, indicates that the drug could relieve lower urinary tract symptoms (LUTS) associated with BPH.

Research was conducted by teams at the University of Texas Southwestern Medical Centre at Dallas, Northwestern University and Lilly Research Laboratories, with more than 1,000 men in ten countries being tested.

The team scored results using the International Prostate Symptom Score and found that all doses of tadalafil were superior to the placebo for relief of LUTS. Patients were given doses of either 2.5, 5.0, 10.0 or 20.0 mg of tadalafil per day.

Claus G Roehrborn MD, from the University of Texas Southwestern Medical Centre, said: "The half-life of tadalafil is 17.5 hours, making it suitable as a once-daily therapy.

Login and visit the BPH Knowledge CentreADNFCR-1419-ID-18746087-ADNFCR

Print Article    Bookmark Bookmark
Related News Stories (Benign Prostatic Hyperplasia (BPH))

FEATURES

DRUG UPDATES Drug updates feed

EMAIL BULLETINS

MEDICAL NEWS EPG News Feed

DISEASE CENTRES Disease Centres feed

RESEARCH

GOOGLE SEARCH

GUIDELINES

DRUG DATA UK Drug Data Feed